Everett Vokes, MD
University of Chicago · The University of Chicago Medical Center · Study Principal Investigator
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Everett Vokes, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:18 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT03944915 · De-Escalation Therapy for Human Papillomavirus Negative DiseaseUniversity of Chicago · completed · Human Papilloma Virus, Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck · principal investigator
- Ph2NCT03107182 · Chemotherapy and Locoregional Therapy Trial (Surgery or Radiation) for Patients With Head and Neck CancerUniversity of Chicago · completed · HPV-Related Squamous Cell Carcinoma, HNSCC · principal investigator
- Ph2NCT02258659 · Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal CancerUniversity of Chicago · completed · Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Oropharynx · principal investigator
- Ph2NCT01693718 · A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck CancerUniversity of Chicago · completed · Head and Neck · principal investigator
- Early Ph1NCT01359267 · Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck CancerUniversity of Chicago · completed · Head and Neck Cancer · principal investigator
- Ph2NCT01185171 · Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head & Neck CancerUniversity of Chicago · completed · Head and Neck Cancer · principal investigator
- Ph1/Ph2NCT00496236 · Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck CancerGenVec · completed · Head and Neck Cancer, Head and Neck Neoplasms · principal investigator
- Ph1/Ph2NCT00496535 · A Study of TNFerade™ Biologic With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients With Head and Neck CancerGenVec · completed · Head and Neck Cancer, Head and Neck Neoplasms · principal investigator
- Ph2NCT00015964 · ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and NeckUniversity of Chicago · completed · Head and Neck Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:18 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Clinical and Experimental TherapeuticsP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI Wendy Stock · fiscal years 2010 to 2026Named on NCT02258659
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.